Welcome to Our Parkinson's Place

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. Please no advertisements.
This is a free site for all.
Thank you.

Friday, June 24, 2011


17th June
2011 - New research


Movement Disorders [2011] June 14 [Epub ahead of print] (Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL.) A study assessing over 20,000 adverse drug reactions has found those drugs that can cause or worsen Parkinson's Disease. This is normally described as drug induced Parkinsonism. Among the suspect drugs, most involved central dopaminergic antagonists (49%), followed by antidepressants (8%), calcium channel blockers (5%), peripheral dopaminergic antagonists (5%), and H1 antihistamines (5%). Cases with lithium, valproic acid, amiodarone, anticholinesterases, or trimetazidine were also found. Some problems occurred due to the interaction of other drugs.

The majority (60%) of people affected were female. Nearly half of all people affected were between 60 and 79 years of age. Seriousness was observed in 44% of cases. Nearly 70% of cases were observed during the first 3 months after introduction of the "suspect" drug (involving mainly central dopaminergic antagonists). A second peak (affecting 20% of cases) was found 12 months after drug introduction (mainly due to calcium channel blockers). The most frequently reported parkinsonian symptom was rigidity. Improvement was favourable after partial or complete withdrawal of suspect drugs in 88% of cases.


23rd June
2011 - New research


Neurology, Neurosurgery and Psychiatry [2011] June 13 [Epub ahead of print] (Uchiyama T, Sakakibara R, Yamamoto T, Ito T, Yamaguchi C, Awa Y, Yanagisawa M, Higuchi Y, Sato Y, Ichikawa T, Yamanishi T, Hattori T, Kuwabara S.)

Urinary dysfunction is common in Parkinson's Disease, but little was known about urinary dysfunction in early and untreated Parkinson's Disease. After excluding those with other conditions that might have influenced urinary function, patients were evaluated using a urinary questionnaire and urodynamic studies. Nearly two thirds (64%) of those people with Parkinson's Disease complained of urinary symptoms. More than a quarter (28%) had urinary difficulty. The main cause
of urinary difficulty is detrusor underactivity. The detrusor is the muscle that contracts when urinating to squeeze out urine. This is because Parkinson's Disease can affect all muscles, including even those used for urinating. Bladder outlet obstruction was present in 16% of people with Parkinson's Disease. Few patients experienced quality-of-life impairment owing to urinary dysfunction, despite the problems it can cause. The urinary symptoms and urodynamic findings were not correlated with gender, type of Parkinson's Disease, or disease severity, and so were not likely to worsen over time. In cases with severe difficulty in urinating, other diagnoses should be considered.